Robotics

Unitree Shares Slide 53 Percent From IPO Peak as China Toughens Humanoid Listing Rules

Unitree Robotics closed at 513.93 yuan on September 9, 2026, down about 53 percent from its debut-day high, as Chinese regulators quietly raised approval standards for humanoid robot IPOs.

T
By TechQuire Daily Staff TechQuire Daily Staff
September 10, 2026 / Updated September 13, 2026 / 7 min read

Unitree Robotics, the Hangzhou-based humanoid robot maker also known as Hangzhou Yushu Technology, made a spectacular debut on the Shanghai Stock Exchange STAR Market on August 19, 2026. Its shares soared 460 percent on the first day of trading, briefly reaching 1,100 yuan, which pushed the company's valuation to nearly 445 billion yuan, or roughly $66 billion. The initial public offering raised about 6.1 billion yuan ($900 million) after pricing at 150.80 yuan per share.

The euphoria did not last. By September 9, 2026, Unitree (ticker 688836) closed at 513.93 yuan ($72.10), down about 39 percent from its 845-yuan debut close and about 53 percent below its first-day high of 1,100 yuan. That decline erased roughly $20 billion in market value from the debut close and about $35 billion from the peak. The Robot Report reported on September 9 that the stock was down 53 percent from its IPO debut.

The retreat has prompted Chinese regulators to act. Reuters reported on September 9 that the China Securities Regulatory Commission has given informal 'window guidance' to some investment banks and firms, raising the bar for approving humanoid startups that plan to go public. According to the report, these companies must prove they can generate recurring revenue and are on track to narrow their losses or achieve real innovation before approvals can be considered.

The change in strategy was prompted by several factors, including a funding frenzy in the private market this year, a long list of companies that have filed for IPOs, and tanking share prices of companies such as Unitree that went public recently. Reuters reported on August 25 that a roughly 45 percent slump in Unitree's shares since its debut had already triggered concerns about bubble risk, retail investor losses, and flaws in the IPO system.

Key Facts

Unitree's September 9 close of 513.93 yuan ($72.10) represents a decline of about 53 percent from its first-day high of 1,100 yuan and about 39 percent from its 845-yuan closing price on debut. Despite the slide, the shares remain more than three times higher than the 150.80-yuan IPO price. At Wednesday's close, the company was worth about $30 billion, which is roughly 125 times its 2025 revenue.

The company generated 1.70 billion yuan ($252 million) in 2025 revenue, up from 392.77 million yuan in 2024. Humanoid robot revenue reached 868 million yuan in 2025, accounting for 51.78 percent of total revenue, and it shipped more than 5,500 humanoids during the year. Unitree projected first-half 2026 revenue of 1.052 billion to 1.128 billion yuan, up roughly 36 percent to 45 percent year over year. The Robot Report reported on September 9 about these figures.

The IPO itself raised about 6.1 billion yuan ($900 million). Before the listing, Unitree targeted roughly 42 billion yuan ($6.2 billion) but ultimately priced at 150.80 yuan per share, valuing it at about 61 billion yuan ($9 billion). Its first-day gain of 460 percent compared with an average first-day gain of 226 percent for newly listed Chinese stocks over the past three years, Reuters reported on August 25.

Reuters reported on September 9 that the China Securities Regulatory Commission's informal guidance requires humanoid startups to demonstrate recurring revenue and a track record of narrowing losses or real innovation before approvals can be considered. The Information originally reported the move, and Reuters could not independently verify it. The report cited people with knowledge of the matter. Chinese financial regulators did not immediately respond to a request for comment.

Adjusted net profit fell 53 percent to 40 million yuan ($5.95 million) in the first three months of 2026, according to Unitree's prospectus. For comparison, Agility Robotics disclosed $1.78 million in 2025 net sales and a $140.2 million operating loss in its S-4 filing for a SPAC with Churchill Capital Corp. XI. The Robot Report reported on September 9 about these figures, highlighting the difference in scale between Unitree and its international peer.

Analysis

The gap between Unitree's operational progress and its market valuation illustrates the tension in the humanoid robot sector. Revenue grew from 392.77 million yuan in 2024 to 1.70 billion yuan in 2025, yet the stock trades at about 125 times 2025 revenue. What this really means is that investors priced in years of future growth that the company has not yet delivered, and the correction is a reality check on those expectations.

The regulatory response is telling. Instead of defending the listing or trying to prop up the stock, the China Securities Regulatory Commission is quietly making it harder for other humanoid startups to follow. The bigger picture here is that Beijing wants to avoid a repeat of the bubble dynamics that left retail investors with losses. By requiring proof of recurring revenue and a path to profitability, regulators are trying to separate genuine innovators from cash-burning hopefuls.

The comparison with Agility Robotics is stark. Unitree's 2025 revenue of $252 million dwarfs Agility's $1.78 million in net sales, but Agility reported a $140.2 million operating loss. Unitree's adjusted net profit fell 53 percent to 40 million yuan in the first quarter of 2026, showing that even the leader faces margin pressure. The judgement is that the humanoid robot sector is entering a phase where execution, not hype, will determine survival. Companies that cannot show a credible path to profitability will struggle to attract public market investors.

Market context matters. China saw only 21 Shanghai IPOs in the first seven months of the year versus 104 in Hong Kong, Reuters reported on August 25. That scarcity helped Unitree's fast-tracked STAR Market listing signal government blessing, but the subsequent slump has made regulators cautious. The explicit judgement is that the era of easy money for humanoid robot IPOs in China is over. Only companies with credible unit economics and a clear route to narrowing losses will get through the approval process.

Why It Matters

For Unitree, the decline erases billions in paper wealth but does not threaten its status as China's best-known humanoid robot maker. It still shipped more than 5,500 humanoids in 2025 and projects strong first-half 2026 revenue growth of 36 percent to 45 percent. However, its high valuation multiple leaves little room for error.

For the broader sector, the regulatory tightening could delay or derail IPOs for dozens of humanoid startups that had hoped to ride Unitree's coattails. Companies must now show recurring revenue and a credible path to narrowing losses, which many early-stage robotics firms cannot do. This could consolidate the industry around a few well-funded players.

For investors, the episode is a reminder of the risks in hot technology sectors. Retail investors who bought at the peak have suffered significant losses, and the wild swings have raised questions about whether enthusiasm for AI and robotics has outpaced fundamentals, as Reuters reported on August 25. The bubble concerns voiced by analysts underscore the caution. Dong Baozhen, chairman of Beijing-based asset manager Lingtong Shengtai, warned that 'all bubbles are doomed to burst.' Abraham Zhang, chairman of venture capital firm China Europe Capital, said the debut 'was not fuelled by a rosy prospect, but a desire by some to pump up the shares so as to dump them later at lofty prices.'

Next Up

Unitree's next earnings report, covering the first half of 2026, will be closely watched for signs that revenue growth is translating into sustainable profits. The company projected revenue of 1.052 billion to 1.128 billion yuan, up 36 percent to 45 percent year over year, but investors will also look at margins and humanoid shipment volumes.

On the regulatory front, the China Securities Regulatory Commission's informal guidance is likely to slow approvals for humanoid IPOs in the coming months. Startups will need to demonstrate recurring revenue and a path to narrowing losses before they can list on the STAR Market. The market will also watch whether other recent listings face similar corrections, and whether the regulatory crackdown extends beyond humanoid robots to other advanced technology sectors. For now, the message is clear: public market investors and regulators are demanding more discipline from a sector that has been fueled by hype.

Tagged

Comments (0)

No comments yet. Be the first to share your thoughts.